Are weight loss drugs like Ozempic changing the way we eat—and the future of the food industry? In this episode of Tech Bites, we delve into the weight-loss drug Ozempic and its profound effects on appetite and food consumption. Originally developed for managing type 2 diabetes, Ozempic is now making headlines for its off-label use in weight loss. We explore how this medication alters people’s relationships with food. Host Jennifer Leuzzi, performance coach at JKL Lifeworks, is joined by Dr. Lisa R. Young, PhD, RDN, CDN, a nutrition and portion control expert, to discuss the health implications, societal impacts, and the potential shift towards healthier food options in a world where appetite suppression is just a prescription away.

LISA R. YOUNG, PhD, RDN, CDN  is an internationally recognized nutritionist, portion size expert, and adjunct professor of nutrition at New York University. Dr. Young is the author of Finally Full, Finally Slim and The Portion Teller Plan. Young has been counseling clients for 3 decades and inspires her community to make healthy food and lifestyle choices.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.